Nutraceuticals in Metabolic Syndrome and Diabetes
- 12 December 2024
- book chapter
- Published by Springer Nature
- p. 123-152
Abstract
No abstract availableKeywords
This publication has 163 references indexed in Scilit:
- In silico studies: Physicochemical properties, drug score, toxicity predictions and molecular docking of organosulphur compounds against Diabetes mellitusJournal of Molecular Recognition, 2021
- Cytokines in type 1 diabetes: mechanisms of action and immunotherapeutic targetsClinical & Translational Immunology, 2020
- Caffeic Acid Alkyl Amide Derivatives Ameliorate Oxidative Stress and Modulate ERK1/2 and AKT Signaling Pathways in a Rat Model of Diabetic RetinopathyChemistry & Biodiversity, 2019
- Metabolic syndrome, Mediterranean diet, and polyphenols: Evidence and perspectivesJournal of Cellular Physiology, 2018
- Prevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009JAMA, 2014
- Effects of dietary polyphenols on neuroregulatory factors and pathways that mediate food intake and energy regulation in obesityMolecular Nutrition & Food Research, 2012
- The anti‐diabetic effect of anthocyanins in streptozotocin‐induced diabetic rats through glucose transporter 4 regulation and prevention of insulin resistance and pancreatic apoptosisMolecular Nutrition & Food Research, 2009
- Astaxanthin protects mesangial cells from hyperglycemia‐induced oxidative signalingJournal of Cellular Biochemistry, 2007
- Prevention of diabetic nephropathy by treatment with astaxanthin in diabetic db/db miceBioFactors, 2004
- Phytochemicals: nutraceuticals and human healthJournal of the Science of Food and Agriculture, 2000